Celsius Therapeutics, Inc. announced it raised $48 Million in an amended filing from an offering of $65 Million
Celsius Therapeutics, Inc. announced it raised $48 Million in an amended filing from an offering of $65 Million
10/04/19, 6:08 PM
Location
cambridgeMoney raised
$48 million
Industry
healthcare
Company Info
Location
399 binney street
cambridge, maryland, united states
Additional Info
Celsius Therapeutics is a clinical-stage biotechnology company focused on developing novel medicines in inflammatory disease. Its lead therapeutic candidate is an anti-TREM1 antibody for the treatment of IBD. Celsius is dedicated to pioneering new therapies and is based in Cambridge, Mass.